| Primary |
| Smoking Cessation Therapy |
84.1% |
| Tobacco Abuse |
3.8% |
| Nicotine Dependence |
3.2% |
| Ex-tobacco User |
2.5% |
| Tobacco User |
1.9% |
| Ex-smoker |
0.7% |
| Hypertension |
0.7% |
| Depression |
0.5% |
| Pain |
0.4% |
| Bipolar Disorder |
0.2% |
| Gastrooesophageal Reflux Disease |
0.2% |
| Thyroid Disorder |
0.2% |
| Vascular Operation |
0.2% |
| Anxiety |
0.2% |
| Bipolar I Disorder |
0.2% |
| Blood Pressure |
0.2% |
| Coagulopathy |
0.2% |
| Diabetes Mellitus |
0.2% |
| Headache |
0.2% |
| Hiv Test Positive |
0.2% |
|
| Vomiting |
25.0% |
| Nightmare |
13.0% |
| Suicidal Ideation |
12.7% |
| Depression |
11.1% |
| Abnormal Dreams |
4.3% |
| Headache |
3.8% |
| Insomnia |
3.6% |
| Mood Swings |
3.6% |
| Nausea |
3.2% |
| Rash |
2.6% |
| Irritability |
2.4% |
| Hallucination |
2.3% |
| Agitation |
2.2% |
| Dizziness |
2.1% |
| Anxiety |
1.6% |
| Somnolence |
1.6% |
| Sedation |
1.5% |
| Feeling Abnormal |
1.2% |
| Constipation |
1.1% |
| Urticaria |
1.1% |
|
| Secondary |
| Smoking Cessation Therapy |
31.1% |
| Drug Use For Unknown Indication |
16.7% |
| Product Used For Unknown Indication |
9.1% |
| Ex-tobacco User |
4.8% |
| Diabetes Mellitus |
4.3% |
| Bipolar Disorder |
3.8% |
| Bronchitis |
3.3% |
| Dyspnoea |
2.9% |
| Pain |
2.9% |
| Post-traumatic Epilepsy |
2.9% |
| Back Pain |
2.4% |
| Depression |
2.4% |
| Acute Coronary Syndrome |
1.9% |
| Anxiety |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Hypertension |
1.9% |
| Schizophrenia |
1.9% |
| Neuralgia |
1.4% |
| Tobacco User |
1.4% |
| Attention Deficit/hyperactivity Disorder |
1.0% |
|
| Completed Suicide |
10.9% |
| Suicidal Ideation |
9.1% |
| Unevaluable Event |
9.1% |
| Mental Status Changes |
7.3% |
| Suicide Attempt |
7.3% |
| Agitation |
5.5% |
| Depression |
3.6% |
| Epistaxis |
3.6% |
| Exposure During Pregnancy |
3.6% |
| Haemoptysis |
3.6% |
| Hallucination |
3.6% |
| Insomnia |
3.6% |
| Lethargy |
3.6% |
| Nicotine Dependence |
3.6% |
| Pharmaceutical Product Complaint |
3.6% |
| Restlessness |
3.6% |
| Sleep Disorder |
3.6% |
| Treatment Noncompliance |
3.6% |
| Vomiting |
3.6% |
| Weight Decreased |
3.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
18.7% |
| Psoriasis |
5.0% |
| Rheumatoid Arthritis |
4.0% |
| Pain |
3.7% |
| Smoking Cessation Therapy |
3.7% |
| Anticoagulant Therapy |
3.3% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Convulsion Prophylaxis |
3.3% |
| Crohn's Disease |
3.3% |
| Hypertension |
3.0% |
| Schizophrenia |
3.0% |
| Asthma |
2.7% |
| Bipolar Disorder |
2.7% |
| Blood Cholesterol Increased |
2.7% |
| Ex-tobacco User |
2.3% |
| Non-small Cell Lung Cancer |
2.0% |
| Percutaneous Coronary Intervention |
2.0% |
| Arthritis |
1.7% |
| Depression |
1.7% |
|
| Convulsion |
8.9% |
| Oedema Mouth |
7.1% |
| Suicide Attempt |
7.1% |
| Tricuspid Valve Incompetence |
7.1% |
| Weight Decreased |
7.1% |
| Musculoskeletal Stiffness |
5.4% |
| Pruritus |
5.4% |
| Schizophrenia |
5.4% |
| Viral Infection |
5.4% |
| Wheezing |
5.4% |
| Drug Interaction |
3.6% |
| Malaise |
3.6% |
| Myositis |
3.6% |
| Nasopharyngitis |
3.6% |
| Nausea |
3.6% |
| Pain |
3.6% |
| Pleural Effusion |
3.6% |
| Pneumonia |
3.6% |
| Pyrexia |
3.6% |
| Renal Failure Acute |
3.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
39.5% |
| Insomnia |
9.3% |
| Smoking Cessation Therapy |
9.3% |
| Anxiety |
7.0% |
| Depression |
4.7% |
| Paranoia |
4.7% |
| Psychomotor Hyperactivity |
4.7% |
| Psychotic Disorder |
4.7% |
| Ex-smoker |
2.3% |
| Hyperlipidaemia |
2.3% |
| Hypertension |
2.3% |
| Hypertriglyceridaemia |
2.3% |
| Induction Of Anaesthesia |
2.3% |
| Nicotine Dependence |
2.3% |
| Obsessive-compulsive Disorder |
2.3% |
|
| Dysgeusia |
20.0% |
| Dysthymic Disorder |
20.0% |
| Drug Interaction |
10.0% |
| Incorrect Dose Administered |
10.0% |
| Pharmaceutical Product Complaint |
10.0% |
| Psychotic Disorder |
10.0% |
| Rhabdomyolysis |
10.0% |
| Vasculitis |
10.0% |
|
